Immunovant, Inc. IMVT
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| Douglas Tsao | H.C. Wainwright | 30.2 $ | 51 $ | 20.80 % | 10/09/2024 |
| Leland Gershell | Oppenheimer | 25.39 $ | 46 $ | 20.61 % | 03/06/2024 |
| Yatin Suneja | Guggenheim | 26.41 $ | 48 $ | 21.59 % | 30/05/2024 |
| Yasmeen Rahimi | Piper Sandler | 27.83 $ | 57 $ | 29.17 % | 30/05/2024 |
| Corinne Johnson | Goldman Sachs | 31.82 $ | 50 $ | 18.18 % | 13/03/2024 |
| Colin Bristow | UBS | 4.88 $ | 5 $ | 0.12 % | 26/09/2022 |